Inherent risk and market acceptance of generic drug products.
The results of a national survey of pharmacists indicate that generic substitutes are less likely to be used for drugs with higher inherent risk. Drugs used to treat chronic disease conditions are viewed as high risk products. Those used to treat symptoms are considered low risk products.